Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
Streaming Delayed Price  /  Updated: 12:14 PM EDT, Apr 24, 2014  /  Add to My Watchlist      
(BAYRY) Community Analysis from
April 24, 2014
(Jutia Group, 9/30/13)
[Reuters] - Germany's Bayer named Pfizer executive Olivier Brandicourt as the new head of its healthcare division, where he will oversee the market launch of a range of...(read more)
(Stock Blog Hub, 7/19/13)
The HealthCare segment of Bayer (BAYRY) recently submitted a regulatory application for its chronic thromboembolic pulmonary hypertension (CTEPH) candidate, riociguat, in Japan. Bayer...(read more)
(Stock Blog Hub, 6/15/13)
Bayer’s (BAYRY) HealthCare segment recently received encouraging news as the US Food and Drug Administration (FDA) approved its oncology drug Xofigo (radium...(read more)
Bayer AG (BAYRY) Company Overview

There is no analysis for BAYRY yet. But you can go to Wikinvest to help create one!

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here